This Week in Psychedelics - 5.7.21

Cannabis

• Mexican Lawmakers Fail To Legalize Marijuana Ahead Of Supreme Court Deadline (Marijuana Moment)

• Alabama Medical Marijuana Bill Heads To Governor’s Desk Following Legislature’s Approval (Marijuana Moment)

• Louisiana House Votes To Legalize Medical Marijuana Flower And Advances Bill To Prepare For Recreational Legalization (Marijuana Moment)

• Texas House Passes Marijuana Decriminalization Bill, Sending It To Senate (Marijuana Moment)

• Philadelphia: Mayor Signs Law Prohibiting Pre-Employment Drug Screening for Cannabis (NORML)

• Frequent Marijuana Consumers Are Actually More Physically Active Than Non-Users, Study Finds, Smashing Stereotypes (Marijuana Moment)

• Neat idea, Canna Bumps: Thanks for keeping marijuana illegal (Leafly)

• Switzerland Just Got One Step Closer to Federally Legalizing Weed (MERRY JANE)

• Cannabis Offers Immediate Nausea Relief, Study Shows (Forbes)

• French Lawmaker Displays Marijuana Joint In Parliament As New Report Calls For Legalization (Marijuana Moment)

• 58% of Americans Don't Know the Difference Between THC and CBD, Survey Says (MERRY JANE)

• Colorado Governor Signs Bill To Expand Medical Marijuana Access For Students In Schools (Marijuana Moment)

• Kansas: House Lawmakers Approve Medical Marijuana Bill (NORML)

• Minnesota Marijuana Legalization Bill Clears 11th House Committee On Path To The Floor (Marijuana Moment)

• Colorado: Legislature Approves Measure Eliminating Civil Penalties for Possessing Between One and Two Ounces of Cannabis (NORML)

• Kansas Lawmakers Approve Medical Marijuana Legalization Bill In Committee (Marijuana Moment)

• Wilmington, Delaware City Council Votes to Support Cannabis Legalization (NORML)

• Cannabis 'gravest threat' to mental health of young people (The Irish Times)

Magic Mushrooms

• MycoMeditations' Psilocybin-Assisted Wellness Retreat Urgently Addresses COVID-19's Impact on Mental Health (PR Newswire)

• Psychedelics and Veganism: Personal Change Catalysed by Psilocybin (Sam Woolfe)

• Psyched Wellness Signs Supply Agreement for Amanita Muscaria (Psilocybin Alpha)

• Psilocybin and the Will to Live (Psychedelic Science Review)

• Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol (Psilocybin Alpha)

MDMA

• A Psychedelic Drug Passes a Big Test for PTSD Treatment (The New York Times)

Mescaline

• A Century of Mescaline (Chacruna)

Synthetic Cannabinoids

• The Power of Synthetic Cannabinoids and Why Big Pharma Prefers Them (Cannabis Science and Technology)

Ketamine

• Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities (Psilocybin Alpha)

• Ketamine, esketamine effective for depression but have limitations (Healio)

• What’s in the ketamine bill that just passed the House Judiciary Committee in Colorado? (KDVR)

Miscellaneous

• 100 Most Influential People in Psychedelics (Psychedelic Invest)

• Texas House Approves Psychedelics Research Bill As Marijuana Reform Measures Also Advance (Marijuana Moment)

• Can a genetic test predict your response to psychedelic drugs? (New Atlas)

• What Happens When Big Pharma Starts Selling Mass-Market Hallucinogens (The Federalist)

• Now that New York Legalized Cannabis, Could Psychedelics Be Next? (DoubleBlind)

• The push to legalize psychedelics has ignored Indigenous communities (Mic)

• Psychedelics at a Crossroads: We Need Constructive Not Extractive Capital (Dr. Bronner's)

• Red Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data (Psilocybin Alpha)

• Psychedelics are transforming the way we understand depression and its treatment (The Irish Times)

• Portland Advocates Push for Psychedelic Decriminalization (Truffle Report)

• Can Psychedelics Provide Relief for Autistic Individuals? (Psychedelics Today)

• Nova Mentis Launches Autism Clinical Study (Psilocybin Alpha)

• Why drugs should be not only decriminalised, but fully legalised (New Statesman)

• Ketanserin’s Contributions to Psychedelic Research (Psychedelic Science Review)

• MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics (Psilocybin Alpha)

• Navigating the Legal Landscape of Psychedelics (Sam Woolfe)

• Culture, entrepreneurial spirit makes Okanagan viable for psychedelic research (iNFOnews)

• Psychedelics and Ecological Consciousness (Reality Sandwich)

• DoubleBlind Editor-in-Chief Shelby Hartman on Covering the World of Psychedelics (Muse by Clio)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.30.21

Cannabis

• Montana Bill To Implement Marijuana Legalization Heads To Governor’s Desk (Marijuana Moment)

• Texas Lawmakers Approve Marijuana And Psychedelics Reform Bills (Marijuana Moment)

• Philadelphia: City Council Votes to Prohibit Pre-Employment Drug Screening for Cannabis (NORML)

• GOP Congressman’s Bill Would Protect Marijuana Consumers’ 2nd Amendment Rights (Marijuana Moment)

• Minnesota Marijuana Legalization Bill Clears Ninth House Committee On Path To Floor (Marijuana Moment)

• Louisiana Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)

• South Dakota Supreme Court Hears Arguments in Litigation Challenging State’s Voter-Approved Marijuana Legalization Initiative (NORML)

• Bolsonaro’s Cabinet Crusade Against Cannabis is Racist and Classist (TalkingDrugs)

• Pennsylvania Marijuana Poll Shows Highest-Ever Support For Legalization (Marijuana Moment)

LSD

• CEO Of $2 Billion Startup Fired After Experimenting With LSD At Work (Forbes)

Magic Mushrooms

• Maine Proposal Would Legalize Psilocybin Mushroom Therapy For Adults, No Medical Diagnosis Needed (Marijuana Moment)

• How an expert psilocybin tester chooses award-winning mushrooms (Inverse)

• Hawaii Legislature Seeks Marijuana Exemption From DEA While Senate Requests Legal Psilocybin Plan (Marijuana Moment)

• Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury (Psilocybin Alpha)

• Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab (Psilocybin Alpha)

• Red Light Holland and Halo Collective Create Red Light Oregon, Inc. – Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market (Psilocybin Alpha)

MDMA

• MDMA-Assisted Therapy for Alcohol Addiction (Spirit Pharmacist)

• Bupropion and MDMA, Risky Combination? (Spirit Pharmacist)

DMT

• PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation (Psilocybin Alpha)

Ayahuasca

• Spain’s (Second to) Last Ayahuasca Trial (ICEERS)

Novel Psychoactive Substances

• Non-hallucinogenic psychedelics: scientists close in on compound (The Guardian)

• Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds (Psilocybin Alpha)

• Eliminating Bad Trips Through Minor Tryptamines (Truffle Report)

• Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003 (Psilocybin Alpha)

Synthetic Cannabinoids

• 'Rising rates' of synthetic marijuana in Iowa prisons prompts investigation (Des Moines Register)

Ketamine

• Bill to regulate ketamine used during police calls passes House committee (Sentinel Colorado)

• Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation (Psilocybin Alpha)

• PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™ (Psilocybin Alpha)

Miscellaneous

• MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq (Psilocybin Alpha)

• Scientists are Using AI to Develop New Psychedelic Drugs (DoubleBlind)

• UCSF Launches New Psychedelic Research Division (Benzinga)

• Drug Possession To Be A Misdemeanor—For Now—Under Washington State Bill Headed To Governor’s Desk (Marijuana Moment)

• Psychedelic drugs without the trip? This sensor could help seek them out (Nature)

• Should Society Legalize Psychedelics? A Breakdown of the Intelligence Squared Debate (Psychedelics Today)

• Native Tribes Should Have More Say in the Psychedelic Movement (Green Entrepreneur)

• This Brain Imaging Device Could Impact Understanding Psychedelic Trips (Healing Maps)

• COMPASS Pathways announces pricing of public offering (Psilocybin Alpha)

• How To Talk With Your Kids About Psychedelics (Psychedelics Today)

• Why Psychedelics, Big in the 1960s, Are Drawing New Interest Now (Bloomberg)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.23.21

Cannabis

• Schumer Celebrates 4/20 Marijuana Holiday On Senate Floor (Marijuana Moment)

• US House Passes Bill To Normalize Adult-Use Cannabis Commerce (NORML)

• Virginia Governor Signs Marijuana Legalization Bill In Ceremonial Event—Even Though It’s Already Enacted (Marijuana Moment)

• New Jersey Supreme Court Rules Company Must Cover Employee's Medical Marijuana Costs (MERRY JANE)

• Nine In Ten Americans Support Legalizing Marijuana For Recreational Or Medical Use, New Pew Poll Finds (Marijuana Moment)

• Florida Supreme Court Kills 2022 Marijuana Legalization Initiative That Hundreds Of Thousands Had Signed (Marijuana Moment)

• Border weed: How the hometown of tater tots became a cannabis capital (Politico)

• Louisiana Lawmakers Approve Bill To Legalize Medical Marijuana Flower For Patients (Marijuana Moment)

• Veterans Medical Marijuana Safe Harbor Act Reintroduced (NORML)

• Minnesota Marijuana Legalization Bill Clears Eighth Committee On Route To The House Floor (Marijuana Moment)

• Two-thirds of La. voters support legalizing marijuana; state lawmakers on both sides of the aisle eye legalization (WAFB)

LSD

• Today Is Bicycle Day, Which Isn’t Quite What You Think (Mother Jones)

• LSD Side-Effects: Risks To Be Aware of When Consuming LSD (The Third Wave)

Magic Mushrooms

• Oregon’s and Compass’s Opposite Approaches to Psilocybin Therapy Should Coexist, Says Initiator of Measure 109 (Chacruna)

• Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application (Psilocybin Alpha)

MDMA

• MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration (The Canberra Times)

• This is why sex on MDMA feels so good, according to experts (Gentside UK)

Ayahuasca

• Advocacy Group Aims to Decriminalize Ayahuasca in Portland (Willamette Week)

• Some Vermonters Turn to Ayahuasca as a 'Last Resort' to Heal Their Bodies and Minds (Seven Days)

5-MeO-DMT

• Researchers In Europe, U.S. Team Up To Produce First Ever 5-MeO-DMT Psychedelic Training Program (Forbes)

• Toad Conservation (Chacruna)

Peyote

• Hello, Religious Privilege is Good and Here's Why (Patheos)

Novel Psychoactive Substances

• 18-MC Has Unique Brain Functions and Mechanisms (Psychedelic Science Review)

Synthetic Cannabinoids

• Study explores synthetic cannabinoid for cancer-related anorexia (Outsourcing-Pharma.com)

Ketamine

• PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

• Ketamine Infusion: How Ketamine Can Treat Depression, Anxiety, PTSD, and More (DoubleBlind)

PCP

• State's medical expert to grand jury: 'Police didn't kill Daniel Prude' (WXXI News)

Miscellaneous

• Norway opposition torpedoes plan to decriminalise drug use (France 24)

• Washington State Lawmakers Downgrade Proposed Drug Possession Penalties Ahead Of House Floor Vote (Marijuana Moment)

• Biden Is Allegedly Planning to Double Down on Trump's Prohibitionist Drug Policies (MERRY JANE)

• MindMed To Commence Trading on Nasdaq (Psilocybin Alpha)

• The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for an Accessible Future (Psychedelics Today)

• Jewish psychedelics movement blasts off with first-ever conference (The Times of Israel)

• ATAI Nasdaq IPO Plans Announced (Truffle Report)

• Researchers Slam Drug War At Federally Hosted Psychedelics Event (Marijuana Moment)

• There’s a Land Grab for Psychedelic Patents: Here’s What We Can Do About It (Psychedelic Times)

• You're Not Hallucinating: Black People Are Being Left Out of the Psychedelic Renaissance (The Root)

• People who regularly use psychoactive substances experienced negative impacts during COVID-19 (News-Medical.net)

• Most Canadians not ready to expand drug legalization beyond cannabis: poll (Coast Reporter)

• Extinction Rebellion founder says psychedelic drugs 'helped start environmental movement' (Wales Online)

• Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica (Psilocybin Alpha)

• Psychedelic Experience launches new website to help navigate the world of psychedelics (PR Newswire)

• The Overlap Between Kink/BDSM and Psychedelics (Chacruna)

• Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction (Psilocybin Alpha)

• Michael Pollan: A Catalyst to the Psychedelic Renaissance (The Third Wave)

• If You're Going to Solo Trip On Psychedelics, Bear This in Mind (VICE)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.16.21

Cannabis

• New Mexico Legalizes Adult-Use Cannabis (Forbes)

• 69 Percent Of Americans Now Support Legalizing Marijuana—An All-Time High, Quinnipiac Poll Finds (Marijuana Moment)

• Marijuana legalization has won (Vox)

• Four More States Could Still Legalize Marijuana This Year After New Mexico, New York And Virginia (Marijuana Moment)

• Nevada Lawmakers Approve Marijuana Bill To Allow On-Site Consumption Lounges (Marijuana Moment)

• Alabama Medical Marijuana Legalization Bill That Already Passed The Senate Heads To House Floor (Marijuana Moment)

• Women Paved the Way for Mexico’s Cannabis Legalization Movement, and Here’s How They Did It (MERRY JANE)

• Limited Tennessee Medical Marijuana Bill Heads To Senate Floor (Marijuana Moment)

• Sixth Minnesota House Committee Approves Marijuana Legalization Bill On Its Path To The Floor (Marijuana Moment)

• Texas Lawmakers Approve Marijuana Decriminalization Bill In Committee (Marijuana Moment)

• With Virginia moving forward, state Democratic leaders want NC to be next to legalize marijuana (Fox 8)

Magic Mushrooms

• Psilocybin Therapy May Work as Well as Common Antidepressant (Scientific American)

• Denver pursues further decriminalization of magic mushrooms (Axios)

• Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits (Neuroscience News)

• Psilocybin Mushrooms Greatly Enhance Creative Thinking, New Clinical Study Confirms (MERRY JANE)

• Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brasil (Psilocybin Alpha)

• Wood Lover’s Paralysis: Psilocybin’s Rare Sickness (Truffle Report)

5-MeO-DMT

• The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Mescaline

• Keepers of the Matrix: A Beginner’s Guide to Understanding Sacred Cacti (DoubleBlind)

Peyote

• Peyote Conservation Group Asks to Include Cultivation in California Decrim Bill (Truffle Report)

Synthetic Cannabinoids

• Why Synthetic Cannabinoids Can Be a Good Thing (Green Entrepreneur)

Miscellaneous

• Psychedelics In Groups? First Study Of Its Kind Shows Potential For Collective Settings (Forbes)

• California Bill To Legalize Possession Of Psychedelics Clears Second Senate Committee (Marijuana Moment)

• Drug-testing to be made permanent at music festivals (Newshub)

• Oregon Legislature Adds Changes to Drug Decriminalization Law (Truffle Report)

• COVID-19 and Psychedelic Group Work: It’s Still Too Soon (Psychedelics Today)

• Washington State’s Drug Policies: Weighing Methods to Decriminalize Possession (Truffle Report)

• Plant Medicine Coalition Launches Grants For Community Healing Hubs in D.C. (Truffle Report)

• Ex Gov. Perry Backs Texas Psychedelics Study Bill (Truffle Report)

• UCSF Launches Translational Psychedelic Research (TrPR) Program (Lucid News)

• YouTube Loosens Restrictions, Expands Monetization for Drug Content (Truffle Report)

• Fireside Project: The 21st Century’s First Psychedelic Peer Support Hotline (Lucid News)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.9.21

Cannabis

• Virginia Becomes First Southern State To Legalize Cannabis (HuffPost)

• How London Could Effectively Decriminalise Cannabis (VICE)

• Mexico Marijuana Legalization Bill Advances In Senate For Second Day In A Row (Marijuana Moment)

• Connecticut Lawmakers Approve Governor’s Marijuana Legalization Bill In Committee (Marijuana Moment)

• Delaware: Cannabis Activists Take on Corporate Marijuana, Patients Stage Boycott (NORML)

• Texas Lawmakers Tackle Marijuana Decriminalization, Medical Cannabis And Hemp In Committee Hearings (Marijuana Moment)

• Alabama House Committee Approves Medical Marijuana Legalization Bill Already Passed The Senate (Marijuana Moment)

• Montana Governor’s Marijuana Bill Revived After Initial Committee Defeat (Marijuana Moment)

LSD

• The History of LSD: From Hero to Villain & Back Again (The Third Wave)

• Legendary LSD Blotter Art: A Hidden Craftsmanship (Reality Sandwich)

Magic Mushrooms

• Denver dabbles with magic mushrooms, but using them to treat mental health disorders remains underground (Los Angeles Times)

• Oregon Health Authority advisory board discusses plan for legal psilocybin (Daily Emerald)

MDMA

• MindMed Announces the Publication of New Data on Personalized MDMA Dosing (Psilocybin Alpha)

5-MeO-DMT

• Hunter Biden says psychedelic toad venom kept him sober for a year (Washington Examiner)

Iboga

• Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction (TIME)

Ketamine

• Ketamine normalizes hyperactivity in key brain region of depressed patients (PsyPost)

Miscellaneous

• Third Massachusetts City Approves Psychedelics Decriminalization Measure (Marijuana Moment)

• California Senators Approve Bill To Legalize Possession Of Psychedelics Like LSD, MDMA And Psilocybin (Marijuana Moment)

• Maine Unveils Legislation to Decriminalize Possession of All Drugs (Filter)

• Is it Possible to Create an Ethical Psychedelics Company? (VICE)

• Psychedelics As Therapeutic Treatments To Be Focus Of New UW-Madison Master's Program (WPR)

• Washington Lawmakers Hear Drug Decrim Bill After Supreme Court Strikes Down Prohibition (Marijuana Moment)

• Drugs Could Soon Be Decriminalised In The Australian Capital Territory. Here's Why That Would Be A Positive Step. (TalkingDrugs)

• Microdosing psychedelic drugs associated with increases in conscientiousness and reductions in neuroticism (PsyPost)

• Ancient cave painters may have been stoned, study says (Salon)

• The Third Wave’s Paul Austin Has Been Accused of Stealing Information For His Psychedelic Provider Directory (Psymposia)

• Can 12-Step Groups and Psychedelic Addiction Treatment Coexist? (VICE)

• Working with Internal Family Systems (IFS) Therapy and Psychedelics: Everything You Need to Know (Psychedelics Today)

• Music is a ‘Hidden Therapist’ in Psilocybin Therapy (Psychedelic Science Review)

• UNDP Brazil Condones Forced Abstinence and Religious Pathologisation of People Who Use Drugs (TalkingDrugs)

• More People Are Self-medicating with Psychedelics, Says New Study (Green Entrepreneur)

• How Do People Even Find Drug Dealers? (VICE)

• ICSS for Assessing the Abuse Potential of Psychedelics (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.